DSM

$87,036P30FY2009CANIH

University Of Virginia, Charlottesville VA

Investigators

Linked publications & trials

Paper 39677791 Paper 39594837 Paper 39487555 Paper 39379376 Paper 39345457 Paper 39333715 Paper 39320053 Paper 39305483 Paper 39300084 Paper 39299754 Paper 39234670 Paper 39229003 Paper 39195207 Paper 39183976 Paper 39182649 Paper 39179415 Paper 39168064 Paper 39120290 Paper 39062532 Paper 39043800 Paper 39026815 Paper 39002133 Paper 38996717 Paper 38979183 Paper 38888326 Paper 38877064 Paper 38856749 Paper 38837261 Paper 38798407 Paper 38707246 Paper 38699302 Paper 38652035 Paper 38650523 Paper 38648258 Paper 38625941 Paper 38614087 Paper 38601144 Paper 38585922 Paper 38554038 Paper 38540794 Paper 38519987 Paper 38519525 Paper 38519053 Paper 38518780 Paper 38485187 Paper 38464674 Paper 38464199 Paper 38460719 Paper 38456462 Paper 38452213 Paper 38409089 Paper 38389838 Paper 38369184 Paper 38356965 Paper 38337036 Paper 38291539 Paper 38272938 Paper 38272221 Paper 38263486 Paper 38255815 Paper 38206848 Paper 38194195 Paper 38178230 Paper 38174422 Paper 38170742 Paper 38148377 Paper 38136410 Paper 38128677 Paper 38109529 Paper 38099095 Paper 38051116 Paper 38019580 Paper 37987094 Paper 37986911 Paper 37953812 Paper 37937078 Paper 37854107 Paper 37815460 Paper 37805600 Paper 37736793 Paper 37732205 Paper 37706194 Paper 37665596 Paper 37509213 Paper 37495573 Paper 37407550 Paper 37298284 Paper 37292058 Paper 37277641 Paper 37205636 Paper 37202597 Paper 37166997 Paper 37159397 Paper 37146074 Paper 37141556 Paper 37131653 Paper 37101403 Paper 37066242 Paper 37058962 Paper 37055441

Abstract

Within the University of Virginia Cancer Center, the Protocol Review Committee, and the Data and Safety Monitoring Committee provide the infrastructure for scientific oversight and monitoring of institutional cancer related clinical trials. The Data and Safety Monitoring Committee provides oversight of the conduct of all ongoing UVa investigator-initiated clinical trials that have been approved by the Protocol Review Committee. For those studies the committee is charged with monitoring, their duties include review of study specific data and safety monitoring plans;adverse events including frequency and patterns of adverse events;protocol violations;audit findings;accrual rates;and adherence to protocol specific escalation or deescalation guidelines, or early stopping guidelines. The protocol specific risk.level assigned by the Protocol Review Committee determines the degree of monitoring.

View original record on NIH RePORTER →